GlobeImmune, Inc. (GBIM)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
At close: Jul 7, 2025
GlobeImmune Revenue
GlobeImmune had revenue of $942.75K in the quarter ending March 31, 2016, a decrease of -20.63%. This brings the company's revenue in the last twelve months to $6.21M, up 8.31% year-over-year. In the year 2015, GlobeImmune had annual revenue of $6.46M with 8.24% growth.
Revenue (ttm)
6.21M
Revenue Growth
+8.31%
P/S Ratio
0.00
Revenue / Employee
2.07M
Employees
3
Market Cap
575.00
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Tian'an Technology Group | 1.78M |
Elite Pharmaceuticals | 84.04M |
Glass House Brands | 215.62M |
American Oncology Network | 1.76B |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |